Key statistics
On Monday, Genmab A/S (GE9:HAN) closed at 196.45, 1.97% above its 52-week low of 192.65, set on Nov 21, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 198.40 |
---|---|
High | 198.40 |
Low | 196.45 |
Bid | 194.75 |
Offer | 196.70 |
Previous close | 197.65 |
Average volume | 0.00 |
---|---|
Shares outstanding | 66.18m |
Free float | 66.16m |
P/E (TTM) | 20.78 |
Market cap | 98.17bn DKK |
EPS (TTM) | 71.38 DKK |
Data delayed at least 15 minutes, as of Nov 25 2024 16:25 GMT.
More ▼
- Genmab to Present at Citi’s Global Healthcare Conference
- Grant of Restricted Stock Units and Warrants to Employees in Genmab
- Genmab Announces Financial Results for the First Nine Months of 2024
- Genmab to Present at Jefferies London Healthcare Conference
- Genmab to Showcase Strength and Breadth of Comprehensive Epcoritamab-bysp Development Program at 2024 American Society of Hematology (ASH) Annual Meeting
- Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2024
- Major Shareholder Announcement
- Investigational Rinatabart Sesutecan (Rina-S) Shows Promising Anti-Tumor Activity as Single Agent in Heavily Pretreated Patients with Ovarian and Endometrial Cancers in Phase 1/2 Clinical Trial
- Capital Increase in Genmab as a Result of Employee Warrant Exercise
- Genmab to Present at Morgan Stanley 22nd Annual Global Healthcare Conference
More ▼